NitricOxide Synthase (NOS) Brain Market, by Product Type (Neuronal NOS (nNOS),Endothelial NOS (eNOS), and Inducible NOS (iNOS)), by End User (ResearchInstitutes, Biotechnology and Pharmaceutical Companies, and Others), and byRegion (North America, Latin America, Europe, Asia Pacific, Middle East, andAfrica) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026
Nitric oxide synthases (NOS) aregroup of enzymes, which convert L-arginine to L-citrulline and produce nitricoxide (NO). Nitric oxide synthases enzymes exhibit a bidomain structurehomologous to cytochrome P450 reductase. There are three isoforms of NOS titledaccording to their function or according to the type of tissue in which theywere first defined. The isoforms of NOS include, neuronal NOS (or nNOS),endothelial NOS (or eNOS), and inducible NOS (or iNOS). These enzymes are alsoreferred numerically: nNOS is referred as NOS1, iNOS as NOS2, and eNOS as NOS3.
Nitric Oxide Synthase BrainMarket Drivers
According to the study publishedby National Center for Biotechnology Information (NCBI) in 2015, nitric oxideis a potential approach for preserving the structural and functional integrityof the brain. This is owing to following properties of nitric oxide: it is apotent vasodilator, released during enhanced neuronal activity resulting fromGlu-ergic activation and it is well suited to mediate the coupling betweenneuronal activity and cerebral blood flow.
* The sample copy includes:Report Summary, Table of Contents, Segmentation, Competitive Landscape, ReportStructure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/2296
Several studies are focused onanalyzing the use of nitric oxide as a treatment and management approach forvarious brain related disorders such as brain injuries, brain ischemia,seizures, memory disorders, neurodegeneration, and neurotoxicity.
Furthermore, increasingprevalence of various brain-related disorders is expected to boost demand fornovel treatment products such as nitric oxide, which in turn is expected todrive growth of the global nitric oxide synthase brain market. For instance,according to the data published by Centers for Disease Control and Preventionin 2017, around 153 people in the U.S. die from injuries that include TraumaticBrain Injury (TBI), every day and TBI accounts for around 30% of allinjury-related deaths.
Nitric Oxide Synthase BrainMarket Regional Analysis
North America nitric oxidesynthase brain market is expected to acquire major share, owing to presence ofkey players in the region and increasing research and development activities.For instance, Enzo Life Sciences, Inc. and Bio-Rad Laboratories, Inc. are twoU.S.-based key players that offer wide range of nitric oxide synthase in NorthAmerica region.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/nitric-oxide-synthase-nos-brain-market-2296
Nitric Oxide Synthase BrainMarket Key Players
Key players operating in theglobal nitric oxide synthase brain market include, Enzo Life Sciences, Inc.,Boster Biological Technology, Merck Group, LifeSpan BioSciences, Inc., RocklandImmunochemicals, Inc., St John's Laboratory Ltd, Biorbyt Ltd, QED BioscienceInc., OriGene Technologies, Inc., Abbexa Ltd., Bio-Rad Laboratories, Inc.,Proteintech Group Inc., Bioss Inc., and BioVision Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/2296
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollaropportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737
